Nature Reviews Gastroenterology & Hepatology, Год журнала: 2023, Номер 20(8), С. 487 - 503
Опубликована: Март 17, 2023
Язык: Английский
Nature Reviews Gastroenterology & Hepatology, Год журнала: 2023, Номер 20(8), С. 487 - 503
Опубликована: Март 17, 2023
Язык: Английский
Cellular and Molecular Immunology, Год журнала: 2020, Номер 18(1), С. 112 - 127
Опубликована: Ноя. 24, 2020
Язык: Английский
Процитировано
240Nature Reviews Gastroenterology & Hepatology, Год журнала: 2021, Номер 19(4), С. 239 - 256
Опубликована: Ноя. 26, 2021
Язык: Английский
Процитировано
234Gut, Год журнала: 2021, Номер 71(9), С. 1867 - 1875
Опубликована: Сен. 6, 2021
Objective Some data suggest a positive association between non-alcoholic fatty liver disease (NAFLD) and incident major adverse cardiovascular events (MACEs). However, are lacking from large cohorts with histology, which remains the gold standard for staging NAFLD severity. Design This population-based cohort included all Swedish adults histologically confirmed without (CVD) at baseline (1966–2016, n=10 422). was defined prospectively recorded histopathology categorised as simple steatosis, non-fibrotic steatohepatitis, non-cirrhotic fibrosis cirrhosis. Patients were matched to ≤5 population controls or CVD, by age, sex, calendar year county (n=46 517). Using Cox proportional hazards modelling, we calculated multivariable adjusted HRs (aHRs) 95% CIs MACE outcomes (ie, ischaemic heart (IHD), stroke, congestive failure (CHF) (CV) mortality). Results Over median of 13.6 years, in 2850 patients 10 648 controls. had higher incidence than (24.3 vs 16.0/1000 person-years (PY); difference=8.3/1000 PY; aHR 1.63, CI 1.56 1.70), including rates IHD (difference=4.2/1000 1.64, 1.54 1.75), CHF (difference=3.3/1000 1.75, 1.63 1.87), stroke (difference=2.4/1000 1.58, 1.46 1.71) CV mortality (difference=1.2/1000 1.37, 1.27 1.48). Rates increased progressively worsening severity (p trend =0.02), highest observed cirrhosis (difference controls=27.2/1000 2.15, 1.77 2.61). Conclusion Compared controls, biopsy-proven significantly MACE, IHD, mortality. Excess risk evident across stages
Язык: Английский
Процитировано
211Nature Reviews Cardiology, Год журнала: 2022, Номер 20(1), С. 24 - 37
Опубликована: Июль 15, 2022
Язык: Английский
Процитировано
196Nature Reviews Gastroenterology & Hepatology, Год журнала: 2023, Номер 20(8), С. 487 - 503
Опубликована: Март 17, 2023
Язык: Английский
Процитировано
195